MedWatch

Genmab drug becomes more accessible in the US

Tepezza, which Genmab developed under the ownership of Horizon Therapeutics, has now entered the portfolio of products offered through the largest group of independent specialty pharmacies in the US.

Photo: Jon Cherry/AFP / GETTY IMAGES NORTH AMERICA

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list Hear.com, which handles online sales.

Further reading

Related articles

Latest news

See all jobs